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Inhalation of Aspergillus fumigatus spores induces airway inflammation in mice in a 
similar manner as observed in Recurrent Airway Obstruction in horses
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RESUMEN
El objetivo de este estudio fue determinar si ratones expuestos a esporas de Aspergillus fumigatus desarrollan una inflamación alérgica de las vías 
respiratorias similar a la observada en equinos con Obstrucción Recurrente de las Vías Aéreas (ORVA). Para esto se utilizaron ratones Rockefeller (RK) 
de 2, 5, 6 y 8 meses respectivamente, los cuales se mantuvieron por 16 días en jaulas que contenían heno contaminado con A. fumigatus. Posterior a 
la exposición, los animales fueron sangrados y sacrificados para la obtención de suero sanguíneo, lavado broncoalveolar (LBA) y muestras de tejido 
pulmonar. Además, se midieron los niveles de anticuerpos específicos para A. fumigatus a través de un ELISA indirecto. Los resultados mostraron que 
la inhalación de esporas de A. fumigatus en ratones induce una respuesta alérgica inflamatoria en pulmones similar a lo observado en ORVA equino, con 
un aumento del porcentaje de neutrófilos en el LBA y cambios histológicos pulmonares característicos de una hipersensibilidad bronquial. Asimismo, 
se observó un aumento de los niveles de inmunoglubulinas IgE, IgG1 e IgG2a específicas para este hongo en fluidos bronquiales. Además, los animales 
remitieron el estrés respiratorio cuando fueron expuestos en un ambiente de remisión. Se puede concluir que la simple exposición de esporas de A. 
fumugatus produce una condición alérgica similar al ORVA en equinos. Por lo tanto, este modelo experimental puede ser de utilidad para el estudio de 
los mecanismos inmunológicos, y probar nuevas opciones terapéuticas para esta enfermedad respiratoria de los caballos.
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INTRODUCTION
Recurrent Airway Obstruction (RAO) in horses, also 
known as heaves, is a complex, severe and common re-
spiratory disorder that affects stabled horses (Dixon et al 
1995, Jackson et al 2000, Robinson 2001). It is caused 
by an aberrant immune response to inhaled antigens and 
is characterized by coughing, respiratory distress, revers-
ible airway obstruction and reduced physical performance 
(Jackson et al 2000, Robinson 2001).
Aspergillus fumigatus is a saprophyte fungus, which 
survives and grows over a large variety of organic re-
mains and whose most common ecological niche is on 
the ground. It is one of the most ubiquitous fungi, due 
to the ease of dispersion of its conidia (Rementeria 
et al 2005). This fungus is commonly found in the horse 
environment and is considered one of the inciting agents 
in equine heaves (McPherson et al 1979, Derksen et al 
1988). Studies suggest that RAO-affected horses have 
higher titers of antibodies to A. fumigatus extracts in 
bronchoalveolar lavage fluid (BALF) compared to healthy 
control horses (Halliwell et al 1993, Schmallenbach et al 
1998, Eder et al 2000). Moran et al (2009) showed that 
healthy and RAO-affected animals have specific circulat-
ing antibodies against the crude mold extract from this 
fungus. In addition, using an in vitro bioassay, Moran 
et al (2010) demonstrated that 30% of thirty RAO-affected 
horses tested positive for A. fumigatus, which indicates a 
wide distribution for this allergen. 
Airway inflammation is a component of a RAO 
affected horse’s response to aeroallergens and is considered 
to be one of the primary characteristics of this disease. 
In general, airway inflammation in RAO-affected horses 
involves the activation of pathogen specific inflammatory 
cells, modulation of gene transcription factors and the release 
of inflammatory mediators (Bureau et al 2000a,b). Type I 
hypersensitivity, which is IgE-mediated (Halliwell et al 
1993, Schmallenbach et al 1998, Eder et al 2000, Eder et 
al 2001, Curik et al 2003, Künzle et al 2007, Tahon et al 
2009, Moran et al 2010a,b), and type III hypersensitivity 
reactions have been suggested to play a role in airway 
inflammation in RAO-affected horses (Franchini et al 
2000, Lavoie et al 2001). 
On the other hand, in humans, A. fumigatus represents 
a real threat for immunocompromised individuals, such as 
patients suffering from leukemia, individuals infected with 
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HIV, and those who have undergone organ transplants. In 
normal individuals, cases of allergic disease and myco-
toxicosis have also been reported (Rementeria et al 2005). 
Several experimental mouse models have been proposed 
for the study of allergic bronchopulmonary aspergillosis 
(ABPA) in humans. The majority of these models require 
parenteral immunization, followed by nasal instillation of 
the antigen. This model results in a Th2-oriented immune 
response, the production of A. fumigatus-specific IgE, and 
eosinophilic pulmonary inflammation (Kurup et al 2001, 
Randolph et al 1999, Huang et al 2001). 
It is commonly accepted that RAO disease is a bronchial 
hypersensitivity reaction induced by inhaled molds and 
organic dust (Derksen et al 1988, McGorum et al 1993). 
However, although the immunological aspects of RAO have 
been extensively studied, the precise sequence of events 
is not fully understood (Leguillette 2003, Wagner 2009). 
In addition, these investigations have been hampered by 
problems with the use of antibodies for the detection of 
equine IgE (Tahon et al 2009) and the lack of suitable 
immunological tools. A rodent model with controlled 
environmental conditions would be useful and may pro-
vide additional information about RAO in horses. In this 
study, we show that mice naturally exposed to A. fumigatus 
develop a disease with characteristics that are similar to 
RAO in horses. These characteristics include remission 
of signs after antigen removal, recurrence of disease upon 
antigen re-exposure, intense neutrophilic infiltration in the 
airways, and histopathological lung changes. 
MATERIAL AND METHODS
ANIMALS 
For all experiments, we used 2- to 8-month-old, sex- 
and age-matched Rockefeller (RK) mice. The animals 
were obtained from, and maintained at the Animal Facility 
of the Universidad Austral de Chile. During exposure to 
A. fumigatus, the animals were placed in an isolation room 
with the appropriate ventilation and filtering systems. This 
study was approved by the Bioethics Committee for the 
Use of Animals in Biomedical Research of the Universidad 
Austral de Chile.
ANTIGENIC PREPARATIONS OF A. FUMIGATUS 
The culturing of A. fumigatus was carried out in two 
steps. The fungus was first cultured in peptone agar for 
7 days at 37 °C and then in malt broth for an additional 
7 days. The resulting fungi were used for soluble protein 
extraction and for the contamination of mouse bedding. For 
protein extraction, fungi were blended and subsequently 
sonicated (Ultrasonic Homogenizer, series 4710 Cole 
Parmer, USA). The resulting suspension was centrifuged 
at 12,500 x g for 10 min and the supernatant, which con-
tained the soluble proteins, was stored at –20 °C for later 
use. To expose mice to A. fumigatus, under conditions that 
are similar to those confronted by horses affected with this 
pathogen, good quality hay was sterilized and sprinkled 
with water containing fungus spores. The contaminated 
hay was then placed into plastic bags and incubated for 
48 hours or more until mold contamination became visible. 
At this point, the contaminated hay was used as bedding 
in the mouse cages. During the experiment, animals were 
maintained under these conditions according to the design 
of each experiment.
EXPOSURE OF MICE TO A. FUMIGATUS SPORES 
Different groups of 2-, 5-, 6- and 8-month-old mice 
(eight mice per group) were housed in cages with sterile 
or A. fumigatus contaminated hay bedding and were kept 
in an isolation room for 16 days. Each day, after being 
exposed to the fungus, the animals were carefully observed 
twice a day for clinical signs of respiratory distress. After 
16 days of mold exposure, the mice were bled and sacri-
ficed to obtain bronchoalveolar lavage fluid (BALF) or 
lung tissues for histological analysis. 
In addition, different groups of 2-, 5-, 6- and 8-month-
old mice (eight mice per group) were used to evaluate the 
recurrence of respiratory distress. For this purpose, the 
animals that were housed in the contaminated environment 
and demonstrated clear signs of respiratory distress (such as 
tachypnea and audible sibilance) were placed in a remission 
environment, allowing us to observe the disappearance of 
signs associated with respiratory distress.
BRONCHOALVEOLAR LAVAGE
Different groups of mice were used for bronchoalveolar 
lavage (BAL) and analysis of lung tissues to prevent any 
possible alterations in the histological appearance of the 
lungs that were due to the lavage. The animals were sac-
rificed using an overdose of a sodium barbital anesthetic 
(Serve, USA). For BAL, the trachea was surgically exposed 
and cannulated with an intravenous catheter (22 G x 1/in), 
and 500 mL of saline solution was slowly administrated 
into the trachea and immediately recovered. The obtained 
BALF was centrifuged at 690 x g, and the supernatant was 
stored at –20 °C for later use. The supernatant was used 
for the analysis of antibody titers, and the cell pellet was 
used for cytological analyses.
ANALYSIS OF ANTIBODY PRODUCTION
The levels of Aspergillus-specific immunoglobulins 
present in BALF and serum were determined by ELISA. 
Briefly, 96-well polystyrene microplates (Sarstedt, USA) 
were coated with 10 mg/ml of A. fumigatus total protein 
that was dissolved in carbonate buffer (pH 9) and incu-
bated overnight. The plates were blocked with a solution 
of 5% non-fat milk, followed by the addition of 100 ml of 
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the appropriate dilution of BALF (1:1) or serum (1:100) 
into each well. The plates were incubated at 37 °C for 2 
hours, washed three times and incubated with peroxidase-
conjugated anti-mouse IgE, IgG1 or IgG2a antibodies 
(Santa Cruz, Inc, USA) for an additional 2 hours at 37 °C. 
After incubation, the plates were thoroughly washed and 
the reaction was revealed with o-phenylenediamine (OPD; 
Sigma, USA). The colorimetric reaction was evaluated 
at 450 nm using a microplate reader (ELx800, Bio-Tek 
Instruments, USA).
CYTOLOGY OF BALF AND HISTOLOGICAL ANALYSIS 
Cells recovered from BALF were resuspended in 100 mL 
of saline solution. A 10 ml drop of this cell suspension was 
dried on a glass slide and stained with May-Grünwald-
Giemsa. For histological sections, control or experimental 
lung tissues were fixed in 4% formaldehyde, embedded 
in Paraplast, cut into 5-mm sections, and stained with 
hematoxylin-eosin (Ortloff et al 2010)
STATISTICAL ANALYSIS
The results of the percentage of neutrophils in the BALF 
and the analysis of the antibody levels were assessed by 
ANOVA. When significant, the means were compared 
using a Tukey's Multiple Comparison Test. The results 
are reported as the mean ± SD. A value of P < 0.05 was 
considered significant.
RESULTS
ANALYSIS OF THE CELLULAR COMPOSITION OF THE BALF
The differential neutrophil counts in the BALF from 
A. fumigatus-exposed and non-exposed mice, which were 
different ages, are shown in figure 1. The cells recovered 
from the BALF of the exposed mice exhibited a sig-
nificant increase in the proportion of polymorphonuclear 
neutrophils. There were significantly greater proportions 
of neutrophils in 5-, 6- or 8-month-old mice that were ex-
posed to A. fumigatus compared to the non-exposed mice. 
Neutrophils were present in the BALF from 2-month-old 
mice that were exposed to A. fumigatus, but there was no 
statistically significant difference in this group compared 
to the non-exposed controls. 
HISTOPATHOLOGICAL EVALUATION 
Figures 2 and 3 demonstrate the histopathological 
changes that occurred in the airways of A. fumigatus-
exposed and non-exposed mice. Clear changes in airway 
histopathology were only observed in mice that were 
older than 5 months of age and had been exposed to 
A. fumigatus for 16 days. No differences were observed 
between exposed and non-exposed mice that were 2 months 
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Figure 1.  Percentage of neutrophils in bronchoalveolar lavage 
after being exposed to sterile hay (open bar) or moldy hay 
(Aspergillus fumigatus) (closed bars) for 16 days (n = 8 mice 
per group). Each bar represents the mean ± SD of the relative 
percentage of neutrophils that were obtained from different 
groups of mice (* P < 0.05 comparing sterile hay to moldy hay 
exposure).
 Porcentaje de neutrófilos en el lavado broncoalveolar des-
pués de ser expuesto al heno estéril (barra abierta) o heno con esporas 
(Aspergillus fumigatus) (barras cerradas) durante 16 días (n = 8 ratones 
por grupo). Cada barra representa la media ± desviación estándar de la 
proporción relativa de los neutrófilos que se obtuvieron de los diferentes 
grupos de ratones (* P < 0,05 se compara el heno estéril con la exposición 
del heno con esporas).
Figure 2. Representative lung histology of one mouse aged 
(5 month-old) that was exposed to sterile hay for 16 days. 
The bronchiole contains no inflammatory cell influx within 
the wall (W), the lumen (L), peribronchial tissue (PI), and the 
surface epithelium. (e) The lining of the bronchiolar lumen is 
thin and composed of cuboidal, ciliated and non-ciliated cells. 
Hematoxylin-eosin stained.
 Histología representativa de pulmón de un ratón de 5 meses 
de edad que se ha expuesto al heno estéril durante 16 días. El bronquiolo 
no contiene células inflamatorias en la pared (W), lumen (L), tejido 
peribronquial (PI), y la superficie del epitelio. (e) El revestimiento del 
lumen bronquial es delgado y está compuesto de células cúbicas, ciliadas 
y no ciliadas. Tinción Hematoxilina-eosina.
of age. The luminal surface epithelium in the bronchiolar 
airways of unaffected, non-exposed mice was composed 
of thin cuboidal epithelial cells. These cells were mostly 
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Figure 3. Representative lung histology of mice (5 and 8 month-old) that were exposed to moldy hay (Aspergillus fumigates) for 
16 days. (A) Severe atelectasia and peribronchiolar and alveolar infiltration by inflammatory cells (white arrows). (B) Peribronchial 
infiltration by polymorphonuclear neutrophils and lymphoplasmacytic cells (white arrows). The bronchiolar lumen was stenosed by 
cells debris (asterisk). (C) Peribronchial infiltration of polymorphonuclear neutrophils and lymphoplasmacytic cells (white arrows). The 
bronchiolar lumen was stenosed by cells debris (black asterisk) and extensive folding of the airway epithelium was observed. Extensive 
folding is a sign of smooth muscle (SM) contraction (white asterisk). Hematoxylin-eosin stained.
 Histología representativa de pulmón de ratones (5 y 8 meses de edad) que fueron expuestas a heno con esporas (Aspergillus fumigatus) 
durante 16 días. (A) atelectasia grave con infiltración peribronquial y alveolar por células inflamatorias (flechas blancas). (B) Infiltración peribronquial 
por neutrófilos polimorfonucleares neutrófilos y células linfoplasmacíticas (flechas blancas). El lumen bronquial se observa estenosado por detritus 
celulares (asterisco). (C) se observa una infiltración peribronquial con polimorfonucleares neutrófilos y células linfoplasmacíticas (flechas blancas). El 
lumen bronquial se observa estenosado por detritus célulares (asterisco negro) y una exfoliación del epitelio respiratorio. Esta exfoliación es un signo 
de contracción (SM) músculo liso (asterisco blanco). Tinción Hematoxilina-eosina. 
non-ciliated clara cells and ciliated cells that were either 
with or without a few intervening mucus cells (figure 2). 
We observed pathological signs in the lungs of animals 
exposed to A. fumigatus. The bronchiolitis observed in 
animals exposed to A. fumigatus was characterized by 
significant peribronchiolar and perivascular mononuclear 
and neutrophilic infiltration, accumulation of intraluminal 
bronchiolar mucus and serofibrinous exudates. Moreover, 
there is extensive folding of the airway epithelia, which is 
a sign of airway smooth muscle contraction and smooth 
muscle hypertrophy. This inflammatory response was 
observed predominantly in the peribronchiolar interstitial 
tissues and often extended into the lamina propria and 
luminal surface epithelium of the affected airways. We 
also observed infiltration of inflammatory cells into the 
alveolar space (figures 3A, 3B and 3C).
ANTIBODY LEVELS IN BALF AND SERUM
BALF from 5-, 6- and 8-month-old mice, which had 
been exposed to A. fumigatus, exhibited a significant in-
crease in fungus-specific IgE, IgG1 and IgG2a antibodies 
when compared to control mice. However, there was no 
significant difference in the levels of A. fumigatus-specific 
antibodies in BALF from 2-month-old mice (figure 4). 
A. fumigatus IgE levels in the serum from the exposed mice 
in all age groups were significantly greater than the serum 
levels in the control mice (figure 5A). However, serum IgG1 
levels were not significantly different (figure 5B). Serum 
IgG2a levels were only significantly different between 
the control mice and exposed mice that were older than 
6 months of age (figure 5C).
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Figure 4.  Level of specific IgE (A), IgG1 (B) and IgG2a (C) 
against Aspergillus fumigatus in BALF from mice that were 
exposed to either sterile hay (open bars) or moldy hay (closed 
bars), 16 days after allergen exposure (n = 8 mice per group). Each 
bar represents the mean of the optical density (OD), which was 
obtained from each of the different groups of mice (*P < 0,05; 
** P < 0,01 comparing sterile hay to moldy hay exposure).
 Nivel de IgE (A), IgG1 (B) y IgG2a (C) específicas contra 
Aspergillus fumigatus en LBA de los ratones que fueron expuestos a 
heno estéril (barras abiertas) o al heno con esporas (barras cerradas), 16 
días después de exposición al alérgeno (n = 8 ratones por grupo). Cada 
barra representa la media de la densidad óptica (DO) que se obtuvo de 
cada uno de los diferentes grupos de ratones (* P < 0.05, ** P < 0.01 se 
compara la exposición del heno estéril con heno con esporas).
Figure 5. Level of specific IgE (A), IgG1 (B) and IgG2a (C) 
against Aspergillus fumigatus in the serum from mice that were 
exposed to either sterile hay (open bars) or moldy hay (closed 
bars), 16 days after allergen exposure (n = 8 mice per group). 
Each bar represents the mean of the optical density (OD), which 
was obtained from each of the different groups of mice (*P < 0,05 
comparing sterile hay to moldy hay exposure).
 Nivel de IgE (A), IgG1 (B) y IgG2a (C) especificas contra 
Aspergillus fumigatus en sueros de los ratones que fueron expuestos a 
heno estéril (barras abiertas) o al heno con esporas (barras cerradas), 16 
días después de exposición al alérgeno (n = 8 ratones por grupo). Cada 
barra representa la media de la densidad óptica (DO) que se obtuvo de 
cada uno de los diferentes grupos de ratones (* P < 0.05, ** P < 0.01 se 
compara la exposición del heno estéril con heno con esporas)
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RECURRENCE OF SIGNS ASSOCIATED WITH RESPIRATORY 
DISTRESS 
Only older mice (5 to 8 months of age) exhibited 
clear signs of respiratory distress, such as tachypnea and 
audible sibilance, 16 days after exposure to A. fumigatus. 
The distressed animals displayed a different behavior 
when compared to control or young mice. The distressed 
mice also showed a tendency to huddle into groups and 
remain still. These animals recovered 7 to 8 days after 
being relocated into a remission environment. After this 
period, the experimental animals were exposed again, 
as previously described, to A. fumigatus. However, the 
mice showed signs of respiratory distress four days after 
exposure. Same as before, the animals recovered when 
they were placed in a remission environment. Antigen 
exposure was repeated one additional time, 2 weeks after 
the final observation of signs associated with respiratory 
distress. This time, the onset of respiratory distress was 
faster (one day after exposure). Once again, the animals 
recovered when placed in a remission environment. 
DISCUSSION
RAO in horses is a far more complex condition than 
allergic diseases, such as insect bite hypersensitivity and 
atopic asthma in humans (Art et al 2008). Advances have 
been made in the understanding of the immunological and 
clinical aspects of RAO in horses. However, it is not yet 
possible to understand the precise mechanism involved 
in RAO immunopathology. For this reason, the goal of 
this study was to generate an experimental mouse model 
of RAO that closely mimics the condition in horses, 
which focused on the different stages of exacerbation. 
Generally, experimental models of various pathophysi-
ological processes are limited because they typically do 
not recapitulate the disease processes that occur in the 
original species. However, murine models have contributed 
to the understanding of the pathogenesis of many diseases 
and the development of new therapies. Studies on the im-
munological mechanisms and factors that contribute to 
the generation of airway inflammation in RAO-affected 
horses have been hampered due to size of the animal, the 
relatively long lifespan and the lack of suitable immuno-
logical tools. The advantages of mouse models include the 
availability of large numbers of animals, ease of handling 
and a large number of immunologic tools. Although there 
are anatomical differences between the murine lung and 
the horse lung, our results demonstrate that exposure to 
A. fumigatus induces airway inflammation in older mice. 
This inflammatory response is characterized by recurrence 
upon antigen re-exposure, enhanced polymorphonuclear 
neutrophil levels in BALF, and histological features that 
are similar to those described for RAO in horses (Kaup 
et al 1990a,b, McGorum et al 1993, Robinson 2001, Kleiber 
et al 2004). This increased immune response is specifically 
localized to the respiratory tract.
In RAO-affected horses, the infiltration of inflamma-
tory cells in the airway and alveoli is diffuse throughout 
the lung. Thus, BAL is utilized to diagnose RAO because 
the inflammatory cells that are recovered should be repre-
sentative of the overall population of cells in any specific 
lobular part and is therefore valid for the diagnosis of 
heaves (McGorum et al 1993a). Neutrophilic inflamma-
tion is the most consistent abnormality that is present in 
BALF from RAO-affected horses (Derksen et al 1989, 
McGorum et al 1993a). Neutrophilia in BALF from horses 
with RAO is positively correlated with airway hyperre-
activity (Derksen et al 1985, Dixon et al 1995, Fairbain 
et al 1993, Robinson 2001). The presence of large numbers 
of neutrophils in the BALF from animals that were older 
than five months is an important finding of our study. 
Our results are coincident with those of a clinical study 
of RAO-affected horses. Furthermore, older animals that 
were exposed to A. fumigatus had a higher percentage of 
neutrophils in the BALF (60% or more), when compared 
to 2-month-old animals (20%). In horses, animals that are 
older than 5 years of age are more frequently affected by 
RAO compared to younger animals, and the prevalence of 
RAO increases with age (Leguillette 2003). Cöutil and War 
(2003) suggest that the incidence of RAO increases until 
the animals reach 7 to 10 years of age. Once the horses 
reach this age, the incidence of RAO remains fairly con-
stant. The same phenomenon was observed in our murine 
model, where airway inflammation and respiratory distress 
were observed in animals that were older than 5 months of 
age. However, in our clinical observations, we have found 
that older horses suffering from RAO sometimes develop 
clinical exacerbations but do not exhibit a high increase 
of neutrophils in the BALF. We presume that this finding 
occurs because these animals are in a more advanced 
stage of the airway remodeling. Airway smooth muscle 
remodeling in RAO-affected horses may be involved in 
airway hyperresponsiveness and chronic lung function 
impairment through mechanism that are comparable to 
human asthma (Herzberg et al 2006).
On the other hand, the main histopathological lesion 
observed in RAO-affected horses is bronchiolitis, which 
is an accumulation of peribronchiolar lymphocytes that 
is accompanied by an increase in intraluminal neutrophils 
(Kaup et al 1990a,b, Lugo et al 2006, Robinson et al 1996). 
The mice in our study developed histopathological changes 
that are coincident with RAO. 
A. fumigatus has been shown to be important in the 
etiology of RAO (Mcpherson et al 1979, Derksen et al 
1988, MacGorum et al 1993a,b). This fungus produces 
small conidia and spores that can remain suspended in 
the air for long periods of time. These factors increase the 
probability of the mold being inhaled by stabled horses 
(Jackson et al 2000). Moreover, this allergen is present, in 
large amounts, in the fodder of Chilean horse farms (Araya 
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and Zaror 1995). RAO in horses is different from ABPA 
in humans. In addition to bronchospasms, mononuclear 
cell infiltration into the lungs, and increased levels of 
A. fumigatus-specific IgE antibodies, human patients 
usually exhibit blood and lung eosinophilia (Greenberger 
et al 2002). The blood and lung eosinophilia is an aspect 
that is shared with the animal models used to study this 
human disease (Grüning et al 1997, Kurup et al 1999, 
Hogoboam et al 1999). Under our experimental conditions, 
the bronchiolitis observed in the mice was characterized by 
neutrophil infiltration with a low presence of eosinophils. 
These findings are similar to the bronchiolitis that occurs 
in RAO-affected horses. 
Compared to healthy animals, horses affected with 
RAO have significantly higher levels of A. fumigatus-
specific IgE and IgG antibodies in their BALF (Halliwell 
et al 1993, Schmallenbach et al 1998). Our results show 
that the immune response against A. fumigatus allergen, 
in mice, is characterized by increased levels of antigen-
specific IgE, IgG1 and IgG2a antibodies in the BALF. 
However, the serum levels of these antibody isotypes did 
not differ between A. fumigatus exposed and non-exposed 
mice, with the exception of IgE and IgG2a. IgE and IgG2a 
were significantly different in 6- to 8-month-old mice. 
The same phenomenon occurs in RAO-affected horses 
(Schmallenbach et al 1998, Eder et al 2000), confirming 
that local and systemic immune responses are likely regu-
lated independently of one another. Our findings, which 
show that IgE and IgG1 are present in the local airways of 
mice, are in agreement with previously published results 
that have shown similar findings in RAO-affected horses 
(Halliwell et al 1993, Schmallenbach et al 1998, Eder et 
al 2000). In our study, we show that animals exposed to 
A. fumigatus showed a significant increase in serum IgE 
levels. However, this increase was not observed for IgG1. 
Although IL-4 stimulates B cell switching to both IgE and 
IgG1, differences exist in the kinetics of isotype switch-
ing in the mouse. The kinetic differences are based on the 
concentrations of IL-4 that are required to induce isotype 
switching and the requirements for co-stimulation (Gascan 
et al 1991, Mandler et al 1993). These observations may 
partly explain the increased serum IgE levels, compared 
to the levels of IgG1, in mice exposed to A. fumigatus. 
The increased serum and BALF IgE levels suggest 
that a type I hypersensitivity response may be involved in 
the pathogenesis of A. fumigatus. Also, the increase in the 
levels of IgG2a in the BALF from mice that were exposed 
to allergen is compatible with a Th1 response (Takaoka et 
al 2001). These findings mimic the conditions typically 
observed in RAO-affected horses that have elevated levels 
of IgGa and IgGb isotypes (Halliwell et al 1993). Moreover, 
IgG2a can activate the complement cascade, which may 
partly explain the increase in neutrophils observed in 
the BALF of mice that were exposed to A. fumigatus. In 
equines, RAO is characterized by neutrophilic bronchiolitis, 
which is considered evidence of a type III response that 
results from antigen-antibody complex formation and the 
subsequent activation of the complement cascade. These 
events, in turn, cause a release of the anaphylatoxin peptides, 
C3a and C5a (Lavoie et al 2001, Franchini et al 2000). 
A recent study that used IL-4, IFN-γ and IL-12 KO mice 
showed that the respective cytokines play an important 
role in the inflammatory process. However, each of these 
cytokines contributes differentially to the inflammatory 
process and their individual contributions are based on 
the route of immunization (Fischer et al 2007). In addi-
tion, some groups have reported different outcomes of the 
inflammatory process depending on whether the antigen 
was delivered orally or nasally. Depending on the route 
of administration, the resulting inflammation can mimic 
either eosinophil- or neutrophil- mediated asthma-like dis-
eases (Kurup et al 2001). Here, the challenge of mice with 
A. fumigatus-contaminated bedding resulted in a signifi-
cant increase in neutrophils in the BALF and changes in 
normal lung histology, which is similar to the condition 
that occurs when horses are exposed to moldy hay.
As mentioned above, IgE-mediated type I reactions and 
type III reactions have been suggested to be involved in the 
pathogenesis of heaves (Halliwell et al 1993, Schmallenbach 
et al 1998, Eder et al 2000, Franchini et al 2000, Eder 
et al 2001, Lavoie et al 2001, Curik et al 2003, Künzle 
et al 2007, Tahon et al 2009, Moran et al 2010a,b). Moreover, 
recent findings suggest that in addition to the contribu-
tion of inflammatory cytokines, such as IL-1β, IL-8 and 
IL-17 (Cordeau et al 2004, Ainsworth et al 2007, Pietra 
et al 2007, Riihimäki et al 2008), helper T lymphocytes 
may contribute to the pathogenesis of heaves through 
their secretion of either Th1 or Th2 cytokines (Giguere 
et al 2002, Ainsworth et al 2003, Horohov et al 2005). 
Resident lung cells have also been implicated in the onset 
of the airway inflammatory response against A. fumigatus. 
Many resident lung cells express lectin and Toll-like recep-
tors that can interact with Aspergillus components. Thus, 
inhalation of the fungus alone may induce the production 
of proinflammatory, Th-1 and Th-2 cytokines, which may 
be sufficient to trigger the onset of respiratory airway 
inflammation (Rementeria et al 2005, Meier et al 2003, 
Berndt et al 2007). In our study, the progressive nature of 
the disease that was induced by fungus aspiration indicates 
that a specific immune response is needed and that this 
response is probably modulated by cytokines coming from 
the innate immune system.
In summary, RAO-affected horses spontaneously 
develop bronchoconstriction and airway inflammation in 
response to specific airborne irritant and allergen exposure 
(Robinson 2001). Clinical manifestation of the disease 
can be tempered by altering environmental conditions 
to minimize exposure to the causative agents. Therefore, 
research using this mouse model for the study of equine 
RAO can offer the opportunity to approximate the im-
munologic response to airborne irritants and allergens as 
well as to evaluate pharmacological therapies. We conclude 
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that simple exposure of mice to moldy hay induces a 
spontaneous condition that is similar to RAO in horses, 
including the recurrent airway inflammation and similar 
histopathological changes. In due time, this procedure 
may constitute an experimental model for RAO because 
the allergic inflammatory reaction we observed here is a 
very complex phenomenon that accurately mimics RAO 
in horses. Further studies are warranted to fully understand 
the pathogenic mechanisms of RAO which, in turn, can 
lead to new treatment approaches.
SUMMARY
The aim of this study was to determine if mice exposed to Aspergillus 
(A.) fumigatus spores develop airway inflammation in a similar manner to 
Recurrent Airway Obstruction (RAO) in horses. Different groups of 2-, 
5-, 6- and 8-month-old Rockefeller (RK) mice were used throughout the 
experiment. The mice were maintained in the animal house for 16 days 
and kept in cages containing hay contaminated with A. fumigatus. After 
16 days of mold exposure, the mice were bled and sacrificed to obtain 
bronchoalveolar lavage fluid (BALF) or lung tissues for histological 
analysis. In addition, we measured the levels of A. fumigatus-specific 
antibodies by ELISA. The results demonstrated that inhalation of 
A. fumigatus spores in mice induced an inflammatory response in 
the lungs that was characterized by peribronchiolar and perivascular 
mononuclear infiltration and bronchiolar luminal exudates. Moreover, 
there was extensive folding of the airway epithelia, which is a sign of 
airway smooth muscle contraction and smooth muscle hypertrophy. In 
addition, we observed a high number of neutrophils and an increase in 
IgE, IgG1 and IgG2a antibodies in the BALF from mice that were older 
than 5 months and were exposed to A. fumigatus. These animals recovered 
from their respiratory distress when they were placed in a remission 
environment. We conclude that simple exposure of mice to moldy hay 
induces a condition that is similar to RAO in horses. Therefore, using 
this mouse model for the study of equine RAO offers the opportunity to 
approximate the immunologic response to airborne irritants and allergens 
as well as to evaluate pharmacological therapies.
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